Pursuant to section 20 of the Medicines Act 1981 (“Act”), the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Apo-Famciclovir Famciclovir 125mg Film coated tablet Apotex NZ Limited Apotex Inc, Toronto, Canada
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Apo-Famciclovir Famciclovir 250mg Film coated tablet Apotex NZ Limited Apotex Inc, Toronto, Canada
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Apo-Famciclovir Famciclovir 500mg Film coated tablet Apotex NZ Limited Apotex Inc, Toronto, Canada
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
APOHEALTH Famciclovir Once Famciclovir 500mg Film coated tablet Apotex NZ Limited Apotex Inc, Toronto, Canada
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Praxbind Idarucizumab 50mg/mL Solution for injection Boehringer Ingelheim (NZ) Limited Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
|
Dated this 16th day of March 2017.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).